Fresenius Medical Care AG Stock

Equities

FME

DE0005785802

Healthcare Facilities & Services

Market Closed - Xetra 11:42:14 2024-05-22 am EDT 5-day change 1st Jan Change
38.75 EUR -2.15% Intraday chart for Fresenius Medical Care AG -7.87% +2.08%
Sales 2024 * 19.57B 21.19B Sales 2025 * 20.32B 21.99B Capitalization 11.37B 12.31B
Net income 2024 * 651M 705M Net income 2025 * 964M 1.04B EV / Sales 2024 * 1.09 x
Net Debt 2024 * 9.92B 10.74B Net Debt 2025 * 8.98B 9.72B EV / Sales 2025 * 1 x
P/E ratio 2024 *
18.1 x
P/E ratio 2025 *
11.9 x
Employees 117,128
Yield 2024 *
2.78%
Yield 2025 *
3.36%
Free-Float 67.83%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.15%
1 week-7.87%
Current month-2.15%
1 month-0.59%
3 months+7.94%
6 months+7.01%
Current year+2.08%
More quotes
1 week
38.71
Extreme 38.71
40.90
1 month
36.57
Extreme 36.57
42.12
Current year
33.88
Extreme 33.88
42.12
1 year
30.16
Extreme 30.16
49.62
3 years
25.95
Extreme 25.95
71.14
5 years
25.95
Extreme 25.95
81.10
10 years
25.95
Extreme 25.95
93.82
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 19-10-31
Director of Finance/CFO 47 23-09-30
Chief Tech/Sci/R&D Officer 65 08-12-31
Members of the board TitleAgeSince
Director/Board Member 57 16-05-11
Director/Board Member 50 23-07-13
Director/Board Member 56 23-07-13
More insiders
Date Price Change Volume
24-05-22 38.75 -2.15% 450,619
24-05-21 39.6 -2.20% 447,946
24-05-20 40.49 +0.07% 236,272
24-05-17 40.46 -3.02% 439,279
24-05-16 41.72 -0.81% 786,412

Delayed Quote Xetra, May 22, 2024 at 11:42 am EDT

More quotes
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.75 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.82%
Consensus